Macarrón, V.; Losantos-GarcÃa, I.; Peláez-GarcÃa, A.; Yébenes, L.; Berjón, A.; FrÃas, L.; MartÃ, C.; Zamora, P.; Sánchez-Méndez, J.I.; Hardisson, D.
A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict® Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma. Cancers 2025, 17, 273.
https://doi.org/10.3390/cancers17020273
AMA Style
Macarrón V, Losantos-GarcÃa I, Peláez-GarcÃa A, Yébenes L, Berjón A, FrÃas L, Martà C, Zamora P, Sánchez-Méndez JI, Hardisson D.
A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict® Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma. Cancers. 2025; 17(2):273.
https://doi.org/10.3390/cancers17020273
Chicago/Turabian Style
Macarrón, VÃctor, Itsaso Losantos-GarcÃa, Alberto Peláez-GarcÃa, Laura Yébenes, Alberto Berjón, Laura FrÃas, Covadonga MartÃ, Pilar Zamora, José Ignacio Sánchez-Méndez, and David Hardisson.
2025. "A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict® Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma" Cancers 17, no. 2: 273.
https://doi.org/10.3390/cancers17020273
APA Style
Macarrón, V., Losantos-GarcÃa, I., Peláez-GarcÃa, A., Yébenes, L., Berjón, A., FrÃas, L., MartÃ, C., Zamora, P., Sánchez-Méndez, J. I., & Hardisson, D.
(2025). A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict® Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma. Cancers, 17(2), 273.
https://doi.org/10.3390/cancers17020273
